story of the week
Pembrolizumab Followed by AVD in Untreated Early Unfavorable and Advanced-Stage Classical Hodgkin Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab Followed by AVD in Untreated Early Unfavorable and Advanced Stage Classical Hodgkin Lymphoma
Blood 2020 Sep 29;[EPub Ahead of Print], PB Allen, H Savas, AM Evens, R Advani, B Palmer, B Pro, R Karmali, E Mou, J Bearden, G Dillehay, R Bayer, RM Eisner, JS Chmiel, KL O'Shea, LI Gordon, JN WinterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.